Results 131 to 140 of about 527,927 (245)

Paclitaxel Drug-Coated Balloon Angioplasty for Medically Refractory Intracranial Atherosclerotic Disease: A US Single-Center Experience With the AGENT Balloon. [PDF]

Stroke Vasc Interv Neurol
Chaudhari A, Rosenstein ZM, Kamal R, Khan N, Almajali M, Ramirez-Abreu D, Al-Ghetaa JK, Ashouri Y, Lin E, Zaidat OO.   +9 more
europepmc   +1 more source

Politics, Institutions and Change Agents

, 2019
The Arab Uprisings started with the Tunisian revolution. These events brought the country to profound change, especially in its institutional asset. Relying on New Institutionalism theory and in particular on the Gradual Change Theory by Mahoney and Thelen, this paper analyses three fundamental dimensions of institutional change in order to establish ...
openaire   +1 more source

Addressing Economic Insecurities Can Improve Patient‐Reported Outcomes in Lupus

Arthritis Care &Research, Accepted Article.
Background Economic insecurities, such as food, housing, transportation, and financial challenges, are modifiable risk factors and influence patient‐reported outcomes (PROs) in systemic lupus erythematosus (SLE). We examined: 1) associations between economic insecurities and PROs; 2) the impact of screening and addressing economic insecurities during ...
Jay Patel, Tripti Singh, Meredith Ingersoll, Shelby Gomez, Amanda Weber, Sarah E. Panzer, Sancia Ferguson, Christie M. Bartels, Shivani Garg   +8 more
wiley   +1 more source

Sequential use of PI3K/AKT/mTOR pathway inhibitors alpelisib and everolimus in patients with hormone receptor-positive metastatic breast cancer. [PDF]

Breast Cancer Res
Shen S, Teysir J, Safonov A, Bromberg M, Chen Y, Ahmed M, Razavi P, Jhaveri K.   +7 more
europepmc   +1 more source

Use of a Molecular Signature Response Classifier to Inform Treatment Selection Improves Clinical Disease Activity Among Patients with Rheumatoid Arthritis Initiating a Biologic or Targeted Synthetic Disease‐Modifying Antirheumatic Drug

Arthritis Care &Research, EarlyView.
Objective We assessed the effectiveness of PrismRA to improve clinical outcomes among patients with rheumatoid arthritis (RA) initiating treatment with a biologic or targeted synthetic disease‐modifying antirheumatic drug (b/tsDMARD). Methods PrismRA incorporated 19 gene expression features and four clinical features to assess a patient's likelihood of
Fenglong Xie, Timothy Beukelman, Nicholas P. McCormick, Jeffrey R. Curtis   +3 more
wiley   +1 more source

Multimodal AI agents for capturing and sharing proteomics laboratory practice. [PDF]

Mol Syst Biol
Skowronek P, Nawalgaria A, Mann M.
europepmc   +1 more source

Immune Checkpoint Inhibitor–Related Myositis and Associated Triad Overlap Syndrome

Arthritis Care &Research, EarlyView.
Objective Immune checkpoint inhibitor (ICI) myositis is a rare but a highly morbid condition, particularly with the ICI myositis triad syndrome of myositis, myocarditis, and myasthenia gravis. We report the clinical characteristics of ICI myositis and all‐cause mortality in these patients.
Selene Rubino, Grant W. Cannon, Brian C. Sauer, Jorge Rojas, Gregory J. Stoddard, Gary A. Kunkel, Jessica A. Walsh, Bryant R. England, Joshua F. Baker, Tawnie J. Braaten   +9 more
wiley   +1 more source

Rheumatologic Manifestations of Patients With Type B Insulin Resistance

Arthritis Care &Research, EarlyView.
Objective The objectives of this study were to identify laboratory and clinical features associated with type B insulin resistance (TBIR), a rare condition caused by autoantibodies that inhibit the insulin receptor, most frequently occurring in the setting of systemic lupus erythematosus (SLE), and to increase awareness of this rare, life‐threatening ...
S. Amara Ogbonnaya, Sandra G. Williams, Raphael A. Kirou, Marissa Lightbourne, Rebecca J. Brown   +4 more
wiley   +1 more source

Strategies to strengthen the clinical accompaniment of nursing students through caring presence in higher education: a conceptual framework. [PDF]

BMC Med Educ
Zulu BM, Du Plessis E, Moagi MM.
europepmc   +1 more source

How do dialysis nurses and AI reason clinically? A scenario-based comparative study. [PDF]

BMC Nurs
Orkaby B, Segev R, Saban M.
europepmc   +1 more source